المؤلفون: Rebecca Anderson, Lance D. Miller, Scott Isom, Jeff W. Chou, Kristin M. Pladna, Nathaniel J. Schramm, Leslie R. Ellis, Dianna S. Howard, Rupali R. Bhave, Megan Manuel, Sarah Dralle, Susan Lyerly, Bayard L. Powell, Timothy S. Pardee

المصدر: Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)

مصطلحات موضوعية: Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2041-1723

URL الوصول: https://doaj.org/article/af7e039587ff405b8de70ccdba887ce2

المؤلفون: Anjali S. Advani, Anna Moseley, Kristen M. O'Dwyer, Brent L. Wood, Min Fang, Matthew J. Wieduwilt, Ibrahim Aldoss, Jae H. Park, Rebecca B. Klisovic, Maria R. Baer, Wendy Stock, Rupali R. Bhave, Megan Othus, Richard C. Harvey, Cheryl L. Willman, Mark R. Litzow, Richard M. Stone, Elad Sharon, Harry P. Erba

المصدر: J Clin Oncol

مصطلحات موضوعية: Cancer Research, Lymphoma, B-Cell, Methotrexate, Oncology, Antibodies, Bispecific, Antineoplastic Combined Chemotherapy Protocols, Humans, Philadelphia Chromosome, ORIGINAL REPORTS, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b948d77ebeed0170e969be6dbea741d9
https://doi.org/10.1200/jco.21.01766

المؤلفون: Rebecca, Anderson, Lance D, Miller, Scott, Isom, Jeff W, Chou, Kristin M, Pladna, Nathaniel J, Schramm, Leslie R, Ellis, Dianna S, Howard, Rupali R, Bhave, Megan, Manuel, Sarah, Dralle, Susan, Lyerly, Bayard L, Powell, Timothy S, Pardee

المصدر: Nature communications. 13(1)

مصطلحات موضوعية: Leukemia, Myeloid, Acute, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Cytarabine, Humans, Caprylates, Mitoxantrone, Sulfides, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::87ef5e92447a689ed99beef0c583a329
https://pubmed.ncbi.nlm.nih.gov/35354808

المؤلفون: Bing He, Chen Zhao, Fengyin Li, Monica L. Guzman, Rupali R. Bhave, Xiaoke Ma, Steven R. Lentz, Hai-Hui Xue, Shuyang Yu, Kai Tan

المصدر: Cell Stem Cell. 21:359-373.e5

مصطلحات موضوعية: 0301 basic medicine, Agonist, Transcription, Genetic, medicine.drug_class, CD34, EP4 Receptor, Biology, Article, Mice, 03 medical and health sciences, chemistry.chemical_compound, Cell Line, Tumor, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Genetics, medicine, Animals, Humans, Alprostadil, Cell Self Renewal, Progenitor cell, Prostaglandin E1, neoplasms, beta Catenin, Drug Synergism, Cell Biology, Hematopoietic Stem Cells, medicine.disease, Xenograft Model Antitumor Assays, Transcription Factor AP-1, 030104 developmental biology, chemistry, Immunology, Imatinib Mesylate, Neoplastic Stem Cells, Cancer research, Molecular Medicine, lipids (amino acids, peptides, and proteins), Stem cell, Proto-Oncogene Proteins c-fos, Receptors, Prostaglandin E, EP4 Subtype, Misoprostol, FOSB, Chronic myelogenous leukemia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6e4044fff1c0a55cb1f1356d5fe6ac8
https://doi.org/10.1016/j.stem.2017.08.001

المؤلفون: Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Migliaccio AR; Altius Institute for Biomedical Sciences, Seattle, Washington., Kosiorek H; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Bhave R; Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina., Palmer J; Mayo Clinic Scottsdale, Arizona., Kuykendall A; Department of Hematologic Malignancy, Moffitt Cancer Center, Tampa, Florida., Mesa R; Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina., Rampal RK; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York., Gerds AT; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Yacoub A; The University of Kansas Cancer Center, Westwood, Kansas., Pettit K; University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan., Talpaz M; University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan., Komrokji R; Department of Hematologic Malignancy, Moffitt Cancer Center, Tampa, Florida., Kremyanskaya M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Gonzalez A; The University of Texas Health Science Center at San Antonio, San Antonio, Texas., Fabris F; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Johnson K; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Dougherty M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., McGovern E; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Arango Ossa J; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Domenico D; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Farnoud N; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Weinberg RS; New York Blood Center, New York, New York., Kong A; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Najfeld V; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Vannucchi AM; University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Arciprete F; Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, Italy., Zingariello M; Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, Italy., Falchi M; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Viale Regina Elena Rome Italy., Salama ME; Sonic Healthcare, Austin, Texas., Mead-Harvey C; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Dueck A; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Varricchio L; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 15; Vol. 29 (18), pp. 3622-3632.

نوع المنشور: Clinical Trial, Phase I; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*/drug therapy , Primary Myelofibrosis*/metabolism , Myeloproliferative Disorders* , Thrombocytopenia*/chemically induced, Humans ; Janus Kinase 2/metabolism ; Cytokines/therapeutic use ; Immunologic Factors/therapeutic use

المؤلفون: Reed DR; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA. drreed@wakehealth.edu., Wooster M; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Isom S; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Ellis LR; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Howard DS; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Manuel M; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Dralle S; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Lyerly S; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Bhave R; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Powell BL; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Pardee TS; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA.

المصدر: Annals of hematology [Ann Hematol] 2023 Apr; Vol. 102 (4), pp. 897-906. Date of Electronic Publication: 2023 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy, Humans ; Adult ; Child, Preschool ; Infant ; Middle Aged ; Treatment Outcome ; Remission Induction ; Alemtuzumab/therapeutic use

المؤلفون: Mascarenhas JO; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Rampal RK; Leukemia Service, Department of Medicine.; Center for Hematologic Malignancies, and.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Kosiorek HE; Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ., Bhave R; Wake Forest Baptist Health, Winston-Salem, NC., Hexner E; University of Pennsylvania, Philadelphia, PA., Wang ES; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Gerds A; Leukemia and Myeloid Disorders Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Abboud CN; Washington University in St. Louis School of Medicine, St. Louis, MO., Kremyanskaya M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Berenzon D; Wake Forest Baptist Health, Winston-Salem, NC., Odenike O; The University of Chicago Medicine and Comprehensive Cancer Center, Chicago, IL., Farnoud N; Center for Hematologic Malignancies, and.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Krishnan A; Center for Hematologic Malignancies, and.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Weinberg RS; New York Blood Center, New York, NY., McGovern E; Center for Hematologic Malignancies, and.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Salama ME; Department of Pathology, Mayo Clinic, Rochester, MN., Najfeld V; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Medina-Martinez JS; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Arango Ossa JE; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Levine MF; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Zhou Y; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Sandy L; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Heaney ML; Department of Medicine, Columbia University Medical Center, New York, NY., Levine RL; Leukemia Service, Department of Medicine.; Center for Hematologic Malignancies, and.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY; and., Mesa RA; Mays Cancer Center at UT Health San Antonio, San Antonio, TX., Dueck AC; Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ., Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

المصدر: Blood advances [Blood Adv] 2020 Oct 27; Vol. 4 (20), pp. 5246-5256.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Blast Crisis*/drug therapy , Pyrazoles*/therapeutic use, Decitabine/therapeutic use ; Humans ; Nitriles ; Pyrimidines ; Treatment Outcome